Firazyr

Showing Topics 1 - 4 of 4

 Firazyr Icatibant Acetate

Icatibant, trade name Firazyr, is medication that has been approved by the European Commission for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.[2] It is not effective in angioedema caused by medication from the ACE inhibitor class, as shown in a 2017 trial.[3] It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors....
Firazyr

Do you use Firazyr and Icatibant? ## Hi, Karen! How are you doing? Have you recently started treatment with it, or are you just looking for information on the drug? In the U.S. Firazyr has orphaned drug status. There really aren't a lot of Firazyr details available, but what I've found is at that link. ...

Updated in Firazyr
 Icatibant Acetate

Icatibant, trade name Firazyr, is medication that has been approved by the European Commission for the symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults with C1-esterase-inhibitor deficiency.[2] It is not effective in angioedema caused by medication from the ACE inhibitor class, as shown in a 2017 trial.[3] It is a peptidomimetic consisting of ten amino acids, which is a selective and specific antagonist of bradykinin B2 receptors....
 NDC 54092-702
Firazyr 30 mg/3ml Subcutaneous Injection, Solution by Shire Us Manufacturing Inc. ## Package Codes: 54092-702-01, 54092-702-02, 54092-702-03 ## Active Ingredients: Icatibant Acetate


Can't Find What You're Looking For? Submit a New Topic Below

No registration needed.
Simply fill out the form below.

 *
What are the main keywords of your topic?


 *

 *


 Optional, stays hidden.
Get notified when a reply is posted here.




5) Text Verification: *
Prevents SPAM.

Click here to show the question



This form will be submitted securely


TRUSTe

Discussion Thread Guidelines: Any participation in the discussion threads signifies your agreement with the Terms of Use and Privacy Policy. (1) Act civilized and be respectful towards others. No profanity, vulgarity or lewd / suggestive content is allowed. (2) Posts encouraging, facilitating, or seeking advice about the abuse of medications or other substances are prohibited. (3) Personal contact information (such as telephone numbers, email addresses, etc) is not allowed to appear on our discussion threads. (4) We do not allow our forums to be used for buying, selling, trading, or for the promotion of a product or service. (5) Posting external links to other web sites is not allowed without our prior approval. (6) We reserve the right to edit or remove content which we find objectionable to the community at our sole discretion.



Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 7 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA